neuro-ophthalmology

Zug, Switzerland & Barcelona, Spain, August 10, 2026 Oculis Holding AG and Accure Therapeutics S.L. have entered into an...

ZUG, Switzerland, Aug. 3, 2026 Oculis announced that the U.S. Food and Drug Administration (FDA) has provided positive pre-Investigational...

October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...